Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Date:11/9/2011

83$ 150,669  Accounts receivable

2,0153,499  Other current assets

2,4862,638  Land, property & equipment, net

85,24591,533  Acquired technology & other non-current assets

17,37018,023Total assets

$ 184,999$ 266,362Liabilities and Stockholders' Equity  Accounts payable and accrued liabilities

$   9,608$   10,680  Total deferred revenues

45,20148,077  Total derivative liabilities

1,2772,271  Total note payable to Siegfried

3,68610,361  Total note payable to Deerfield (2)

13,76937,777  Total lease financing obligations & other long-term liabilities

76,31977,181  Total stockholders' equity

35,13980,015Total liabilities & stockholders' equity

$ 184,999$ 266,362(1)

The Condensed Consolidated Balance Sheet Data has been derived from the audited financial statements as of that date.(2)

The outstanding principal balance of the note payable to Deerfield was $22.3 million at September 30, 2011 and $60.0 million at December 31, 2010.Contacts:

Arena Pharmaceuticals, Inc.

Robert E. Hoffman

Vice President, Finance and Chief Financial Officer858.453.7200, ext. 222

Investor Inquiries: Russo Partners

Cindy McGee, Vice President

cindy.mcgee@russopartnersllc.com

619.308.6538Media Inquiries: Russo Partners

David Schull, President

david.schull@russopartnersllc.com

858.717.2310
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
2. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
3. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
5. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
7. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
8. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
9. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... According to a new market ... Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and ... and Forecast (Value and Volume), 2013 - 2019", the ... in 2012 and is expected to grow at a ... USD 32.24 billion in 2019. Browse the ...
(Date:7/25/2014)... 25, 2014  IDEXX Laboratories, Inc. (NASDAQ: ... quarter of 2014 increased 11% versus the prior year ... for the second quarter of 2014 versus the prior ... in distributor inventory 2 . Earnings per diluted share ... 11% from the prior year period to $1.10."In the ...
(Date:7/25/2014)... 2014 Leading events organizer UBM Live ... the seventh year to São Paulo, Brazil ... 2014. The event will co-locate with Food Ingredients South America ... meeting point for the pharmaceutical industry.      (Logo: ... pharmaceutical sales are now exploring the South America ...
Breaking Medicine Technology:Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33
(Date:7/26/2014)... WA (PRWEB) July 26, 2014 According ... by Vkool.com, this is a comprehensive guide that covers ... (KP) effectively without the need of any medication. ... book consists of natural and safe remedies for relieving ... book, people will learn:,     How to ...
(Date:7/26/2014)... The birth control safety center at DrugNews.net ... new legal information on the site. A federal panel ... lawsuits pending for July alleging side effects from the ... using popular prescription drugs and medical devices. By giving ... news all in one place, they can see if ...
(Date:7/25/2014)... (PRWEB) July 26, 2014 ... China Gel Permeation Chromatography Industry” is a ... Global and China Gel Permeation Chromatography market. ... information, including Gel Permeation Chromatography definition, classification, ... as industry overview. This research covers the ...
(Date:7/25/2014)... July 26, 2014 According to ... Market by Product (vibration monitoring, thermography, ultrasound emission, ... analysis), Component, Application and Geography - Global Forecast ... machine health monitoring market is expected to reach ... to 2020. , Browse 117 market data Tables ...
(Date:7/25/2014)... As reported by the Statesman Journal in the article ... in Salem, MA as well as several other states are ... that has taken many lives during the past couple of ... which police were able to make two arrests by following ... be the victim and claiming to want to buy more ...
Breaking Medicine News(10 mins):Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3Health News:DrugNews Adds Latest Court Updates on Mirena IUD Lawsuits 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Multiple States Crack Down on Heroin Epidemic 2
... handle large numbers of patients as outbreak spreads , SATURDAY, ... the H1N1 swine flu a national emergency. , His proclamation, ... morning, will allow hospitals and doctors, offices to get legal ... of sick people as the outbreak spreads. , "The H1N1 ...
... ... ... -- According to the Centers for Disease Control and Prevention, the H1N1 (swine) flu virus ... that hospitalizations of related cases have been above average for this time of year. This ...
... ... ... it has signed an exclusive royalty-bearing license agreement, for the Latin American territory, to ... treat a variety of musculoskeletal diseases., , ,Stematix which is establishing international therapy clinics ...
... ... it,s Food, Dairy, Paint, and Craft businesses to focus on their growing Medical business according ... ... Solon Manufacturing Co., a leading maker of single use disposable products for the medical, industrial ...
... ... to college students , ... VA (PRWEB) October 23, 2009 -- The National Alliance on Mental Illness (NAMI) ... and important topic of mental illness through their recent show "Colleges See Rise In Mental ...
... Media ... (Vocus) October ... raise awareness about breast reconstruction options, the Out of the Shadows…Into the Light exhibit shares ... are told through plaster busts, which represent various stages of breast cancer – from none, ...
Cached Medicine News:Health News:Obama Declares Swine Flu a National Emergency 2Health News:Obama Declares Swine Flu a National Emergency 3Health News:Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 2Health News:Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 3Health News:Stematix™ Obtains Exclusive License to Regenexx™ Stem Cell Procedure Treating Musculoskeletal Diseases in Latin America 2Health News:Stematix™ Obtains Exclusive License to Regenexx™ Stem Cell Procedure Treating Musculoskeletal Diseases in Latin America 3Health News:Solon Manufacturing Co. Sells Food, Dairy, Paint, & Craft Businesses; To focus on their growing Medical Device Business 2Health News:NAMI Applauds NPR Story Highlighting Mental Health on Campus 2Health News:Breast Cancer Art Shares Journeys of Hope, Reconstruction 2
... 45° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
... The 45° Prism ... fundus pathologies and are ... detachments (PDR, BRVO etc.) ... They can be used ...
... The Chalam 15° Prism are ... and are recommended for tractional ... and Rhegmatogenus retinal detachment. They ... photocoagulation and other midperipheral laser ...
The Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens....
Medicine Products: